10 results
8-K
EX-99.1
STIM
Neuronetics Inc
7 May 24
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
7:31am
with medical experts. Regardless of practice size or tenure, this program aims to address reported responsiveness issues and lack of knowledge of TMS
8-K
EX-99.1
STIM
Neuronetics Inc
5 Mar 24
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
7:31am
with medical experts. Regardless of practice size or tenure, this program aims to address reported responsiveness issues and lack of knowledge
8-K
EX-99.1
STIM
Neuronetics Inc
7 Nov 23
Neuronetics Reports Third Quarter 2023 Financial and Operating Results
7:31am
of patient care and responsiveness developed in collaboration with medical experts. Regardless of practice size or tenure, this program aims to address
8-K
EX-3.1
STIM
Neuronetics Inc
29 Dec 22
Departure of Directors or Certain Officers
4:15pm
be fixed by or in the manner designated by the Board of Directors.
Section 28. Tenure And Duties Of Officers.
(a) General. All officers shall hold
8-K
EX-3.2
STIM
Neuronetics Inc
29 Dec 22
Departure of Directors or Certain Officers
4:15pm
and other compensation of the officers of the corporation shall be fixed by or in the manner designated by the Board of Directors.
Section 28. Tenure
8-K
EX-99.1
2kzzfjeoopz4bhx9i
2 Jul 19
Neuronetics Appoints Stephen Furlong as Chief Financial Officer
5:17pm
8-K
EX-3.2
r9apyxk7krp4o5s1pi
6 Jul 18
Amendments to Articles of Incorporation or Bylaws
1:48pm
S-1
EX-3.4
tyjs55 darh
31 May 18
IPO registration
12:33pm
DRS/A
EX-3.4
bvqk5el3ol7v2
29 May 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next